Nalaganje...
Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer.
OBJECTIVE:To evaluate the efficacy and safety of gemcitabine (GEM) at 30 min standard-dose infusion (30 min-SDI) compared with prolonged low-dose infusion (P-LDI) in patients with advanced non-small-cell lung cancer (NSCLC). METHODS:Electronic databases including Pubmed, EMbase, Cochrane Library, CN...
Shranjeno v:
Main Authors: | , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Public Library of Science (PLoS)
2018-01-01
|
Serija: | PLoS ONE |
Online dostop: | http://europepmc.org/articles/PMC5862432?pdf=render |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Nalaganje...